Buscar

Estamos realizando la búsqueda. Por favor, espere...

 Detalle_Publicacion

Biomarker testing in advanced non-small-cell lung cancer: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology.

Abstract: In 2011, the Spanish Society of Medical Oncology and the Spanish Society of Pathology started a joint project to establish recommendations on biomarker testing in patients with advanced non-small-cell lung cancer based on the current evidence. Most of these recommendations are still valid, but new evidence requires some aspects to be updated. Specifically, the recommendation about which biomarkers to test in which patients is being amended, and the best way to manage tumour samples and minimum requirements for biomarker test material are defined. Suitable techniques for testing for epidermal growth factor receptor mutations and anaplastic lymphoma kinase rearrangement are also reviewed, and a consensus is reached on which situations warrant re-biopsy.

Otras publicaciones de la misma revista o congreso con autores/as de la Universidad de Cantabria

 Fuente: Clinical and Translational Oncology, 2015, 17(2), 103-112

Editorial: Springer-Verlag Italia

 Año de publicación: 2015

Nº de páginas: 10

Tipo de publicación: Artículo de Revista

 DOI: 10.1007/s12094-014-1248-9

ISSN: 1699-048X,1699-3055

Autoría

FELIP E.

CONCHA Á.

GARRIDO P.

RAMÍREZ J.

ISLA D.

SANZ J.

PAZ-ARES L.

LÓPEZ-RÍOS F.